Literature DB >> 23465502

Impaired vitamin D metabolism in CKD.

Cortney Bosworth1, Ian H de Boer.   

Abstract

Vitamin D metabolism consists of both production and catabolism, which are enzymatically driven and highly regulated. Renal vitamin D metabolism requires filtration and tubular reabsorption of 25-hydroxyvitamin D and is regulated by parathyroid hormone, fibroblast growth factor-23, and 1,25-dihydroxyvitamin D. In chronic kidney disease, renal production of 1,25-dihydroxyvitamin D from 25-hydroxyvitamin D is reduced. In addition, pharmacokinetic studies and epidemiologic studies of 24,25-dihydroxyvitamin D, the most abundant product of 25-hydroxyvitamin D catabolism by CYP24A1, suggest that vitamin D catabolism also is reduced. New insights into the mechanisms and regulation of vitamin D metabolism may lead to novel approaches to assess and treat impaired vitamin D metabolism in chronic kidney disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23465502      PMCID: PMC3592201          DOI: 10.1016/j.semnephrol.2012.12.016

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  140 in total

1.  Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women.

Authors:  Cheryl L Rock; Jennifer A Emond; Shirley W Flatt; Dennis D Heath; Njeri Karanja; Bilge Pakiz; Nancy E Sherwood; Cynthia A Thomson
Journal:  Obesity (Silver Spring)       Date:  2012-03-08       Impact factor: 5.002

2.  Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects.

Authors:  J G Haddad; C Min; M Mendelsohn; E Slatopolsky; T J Hahn
Journal:  Arch Biochem Biophys       Date:  1977-08       Impact factor: 4.013

Review 3.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  Arch Biochem Biophys       Date:  2011-11-12       Impact factor: 4.013

4.  Serum 25-hydroxyvitamin D in patients with chronic renal disease.

Authors:  J Pietrek; F Kokot
Journal:  Eur J Clin Invest       Date:  1977-08       Impact factor: 4.686

5.  Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.

Authors:  Y Weisman; Z Eisenberg; L Leib; A Harell; S M Shasha; S Edelstein
Journal:  Br Med J       Date:  1980-09-13

6.  Intestinal 1,25-dihydroxyvitamin D3 binding protein: specificity of binding.

Authors:  J A Eisman; H F DeLuca
Journal:  Steroids       Date:  1977-08       Impact factor: 2.668

7.  Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.

Authors:  Yoshiko Shimamura; Kazu Hamada; Kosuke Inoue; Koji Ogata; Masayuki Ishihara; Toru Kagawa; Mari Inoue; Shimpei Fujimoto; Mika Ikebe; Kenji Yuasa; Shigeo Yamanaka; Teturo Sugiura; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2012-03-29       Impact factor: 2.801

8.  Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study.

Authors:  Ian H de Boer; Gregory Levin; Cassianne Robinson-Cohen; Mary L Biggs; Andy N Hoofnagle; David S Siscovick; Bryan Kestenbaum
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

9.  Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.

Authors:  Ishir Bhan; Camille E Powe; Anders H Berg; Elizabeth Ankers; Julia B Wenger; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Kidney Int       Date:  2012-03-07       Impact factor: 10.612

10.  The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease.

Authors:  Cortney Bosworth; Ian H de Boer; Giovanni Targher; Jessica Kendrick; Gerard Smits; Michel Chonchol
Journal:  Clin Nephrol       Date:  2012-05       Impact factor: 0.975

View more
  32 in total

1.  Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.

Authors:  Idris Guessous; William McClellan; David Kleinbaum; Viola Vaccarino; Henry Hugues; Olivier Boulat; Pedro Marques-Vidal; Fred Paccaud; Jean-Marc Theler; Jean-Michel Gaspoz; Michel Burnier; Gérard Waeber; Peter Vollenweider; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

2.  Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.

Authors:  Charles Ginsberg; Leila R Zelnick; Geoffrey A Block; Glenn M Chertow; Michel Chonchol; Andrew Hoofnagle; Bryan Kestenbaum; Ian H de Boer
Journal:  Nephrol Dial Transplant       Date:  2020-04-01       Impact factor: 5.992

Review 3.  The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.

Authors:  Gerardo Sarno; Giuseppe Daniele; Giacomo Tirabassi; Alberto O Chavez; Opeolu O Ojo; Francesco Orio; Hana Kahleova; Giancarlo Balercia; William B Grant; Paride De Rosa; Annamaria Colao; Giovanna Muscogiuri
Journal:  Endocrine       Date:  2015-05-22       Impact factor: 3.633

4.  Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Authors:  Leila R Zelnick; Ian H de Boer; Bryan R Kestenbaum; Michel Chonchol; Jessica Kendrick
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-07       Impact factor: 8.237

Review 5.  Vitamin D and Calcimimetics in Cardiovascular Disease.

Authors:  Kenneth Lim; Takayuki Hamano; Ravi Thadhani
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

6.  Compromised Activation of Vitamin D After Elective Surgery: A Prospective Pilot Study.

Authors:  Martin Blomberg Jensen; Henrik Husted; Poul Jannik Bjerrum; Anders Juul; Henrik Kehlet
Journal:  JBMR Plus       Date:  2018-05-22

7.  Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.

Authors:  Ian H de Boer; Leila R Zelnick; Julie Lin; Debra Schaumberg; Lu Wang; John Ruzinski; Georgina Friedenberg; Julie Duszlak; Vadim Y Bubes; Andrew N Hoofnagle; Ravi Thadhani; Robert J Glynn; Julie E Buring; Howard D Sesso; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-09-30       Impact factor: 2.226

Review 8.  Pragmatic Clinical Trials in CKD: Opportunities and Challenges.

Authors:  Ian H de Boer; Csaba P Kovesdy; Sankar D Navaneethan; Carmen A Peralta; Delphine S Tuot; Miguel A Vazquez; Deidra C Crews
Journal:  J Am Soc Nephrol       Date:  2016-06-09       Impact factor: 10.121

9.  Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

Authors:  Zona Batacchi; Cassianne Robinson-Cohen; Andrew N Hoofnagle; Tamara Isakova; Bryan Kestenbaum; Kevin J Martin; Myles S Wolf; Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-02       Impact factor: 8.237

10.  Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.

Authors:  Ian H de Boer; Michael C Sachs; Michel Chonchol; Jonathan Himmelfarb; Andrew N Hoofnagle; Joachim H Ix; Robin A Kremsdorf; Yvonne S Lin; Rajnish Mehrotra; Cassianne Robinson-Cohen; David S Siscovick; Michael W Steffes; Kenneth E Thummel; Russell P Tracy; Zhican Wang; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2014-04-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.